Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo

NVIDIA BioNeMo Service is a cloud service for generative AI in early drug discovery focusing on proteins and small molecules. BioNeMo can be accessed through a web interface or API endpoints and outputs can be visualized and downloaded. AI models in BioNeMo can be further fine-tuned and trained on customers’ proprietary data on DGX Cloud. Nine AI biomolecular models are now accessible in one place: - 3D protein structure prediction: DeepMind’s AlphaFold2, OpenFold, Meta’s ESMFold -Protein property prediction: Meta’s ESM-2 and ESM-1nv based on Meta’s ESM-1 -Small molecule generation: AstraZeneca's MegaMolBART and Weill Cornell Medicine’s MoFlow -Protein generation: ISMB and University of Bayreuth’s ProtGPT2 -Molecular docking: MIT Jameel Clinic’s DiffDock